OTCPicks.com Stocks to Watch for Tuesday, February 9th

2/8/2010 8:29 PM

Penny Stocks by: OTC Picks

Buy RELM Online for $0. Trade stocks for free on Zecco.com.

OTCPicks.com Stocks to Watch for Tuesday, February 9th RELM, AGHD, CLSC, SHMN, CDIV, IRSN Our Stocks to Watch tomorrow include RELM Holdings Inc. (OTC: RELM), AuGRID Global Holdings Corp. (OTC: AGHD), Cobalis Corp. (OTC: CLSC), SOHM Inc. (OTC: SHMN), Cascadia Investments Inc. (OTC: CDIV) and Irvine Sensors Corp. (Nasdaq: IRSN).

RELM HOLDINGS INCORPORATED (OTC: RELM) "Up 155.56% on Monday" Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N0&L8&F=T RELM was incorporated to acquire operating businesses and is now a holding company with a primary focus on financial and information technology services along with real estate. The Company bases its business model on the acquisition of synergistic businesses with the capability to support and compliment its financial and technology products. RELM intends to lead a vertically integrated family of companies that will provide business solutions along with its affiliates to address underwriting, servicing, raising capital, and commercialization, while securitizing and guaranteeing its products in the marketplace. Since 1994 the Company has conceived, designed, and developed innovative, new products that "absorb asset risk." RELM News:

January 5 - RELM Holdings Inc. Provides Management Update on Planned Acquisitions RELM Holdings Inc. (OTC: RELM) management issued the following update on the current status of the three announced pending acquisitions.

The South-Eastern Document Management Company:

Management is continuing to perform its due diligence on the Company and expects to complete its analysis soon. To date, nothing has been found to deter Management from moving forward with this transaction. Once the analysis is complete, Management will work with the Company to finalize the appropriate Purchase Agreement and related documents. In the interim, Management continues its effort to secure funding for all the pending transactions.

The Delaware based Full Service Technology Support Company:

The parties failed to execute a Definitive Purchase Agreement within the time specified in the Letter of Intent (12/31/09). Management is committed to this acquisition and will continue to pursue an agreement; however, management is unable to commit to a timeframe for an agreement at this time.

The West Coast Document Management Company:

Management has successfully completed its due diligence on the Company and is enthusiastic about working with the Company to finalize the Purchase Agreement and to close the transaction within the first quarter of 2010.

ABOUT AVI AVI was organized in 2008 and in 2009 acquired Versalign Inc., which was founded in 1985 and currently provides targeted Information Technology solutions for corporate, professional and governmental clients in the Mid-Atlantic region. AVI provides RELM access to cash flows and expanded business opportunities in the information technology industry.

AUGRID GLOBAL HOLDINGS (OTC: AGHD) "Up 351.61% on Monday" Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N0&L97&F=T AuGRID Global Holdings Corporation is a holding company that seeks to increase its asset base and shareholder value through the acquisition of private companies in diverse industries that have proven revenue generation abilities, defensible business plans, and a product or service to which its target market has demonstrated receptiveness.

AGHD News:

January 4 - J & K Futures, Inc. Finalizes Agreement for Acquisition by AuGRID Global Holdings Corporation AuGRID Global Holdings Corporation (OTC: AGHD) announces that it finalized a purchase agreement to acquire J & K Futures Inc. The Company updated their status and financial information on the Pink Sheets Electronic OTC Exchange. As a result the stop sign was removed. Management is aggressively pursuing the removal of the limited sign in the near future.

J & K Futures provides investors a system of margin Forex trading, creating an opportunity for investors to maximize profits from relatively low initial capital requirements. AuGRID intends to immediately combine J & K Futures with our previous acquisition First Wall Street Group.

The acquisition includes significant synergistic capabilities and alliances consistent with the hard assets, proprietary software and an integrated business plan of both companies. J & K Futures and First Wall Street Group.

AuGRID Global Holdings will continue to focus on acquiring synergistic companies. Currently AuGRID Global Holdings has four additional acquisitions under review by securities counsel and AuGRID`s corporate investigator. Upon Completion of the scheduled due-diligence each acquisition will bring an increase in assets, revenue, broader management, and intended increase in Shareholder value.

COBALIS CORPORATION (OTC: CLSC) "Up 45.45% on Monday" Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N0&L93&F=T Headquartered in Laguna Beach, California, Cobalis Corp. is an over-the-counter pharmaceutical company. Its flagship product PreHistin is designed to prevent the primary causes of airborne allergies, and is set for launch in February 2009. The anti-allergy market is projected to exceed $10 Billion annually by 2010, and PreHistin is poised to capture significant market share. PreHistin is singularly positioned as it is the only Phase III clinically tested sublingual anti-allergy product with demonstrated efficacy.

CLSC News:

November 19 - Cobalis Corp, Maker of Revolutionary Allergy Relief Product PreHistin `The World`s FIRST Prehistamine` Confirms Filing of Five Count Lawsuit Against Yorkville Advisors/YA Global Investments, L P f/k/a Cornell Capital Partners, L P in US Bankruptcy Court Cobalis Corporation (OTC: CLSC) confirms filing Five Count Adversarial Complaint on November 9, 2009 against secured creditor Yorkville Advisors/YA Global Investments, L P (YAGI) f/k/a Cornell Capital Partners, L P in US Bankruptcy Court, Santa Ana, CA.

Yorkville Advisors LLC (YA) is a consultancy that arranges financings for public companies using a technique known as Private Investment in Public Equities (PIPE). It has been alleged that YAGI and its predecessor Cornell are one of the largest investors in PIPE transactions and may have entered into over 300 transactions with publicly traded companies.

On December 20, 2006, Cobalis entered into a Securities Purchase Agreement with Cornell whereby Cornell agreed to purchase up to $3,850,000 of convertible debentures from Cobalis which could be converted into Cobalis common stock. The transaction is considered a PIPE transaction as commonly referred to in the securities industry.

Over the next two to three years and beginning in April 2007, just four months after the PIPE agreement was signed, YAGI sold over 15,000,000 shares of Cobalis stock pursuant to their joint disclosure statement filing with the bankruptcy court. From April 2007 to July 2007, Cobalis Corporation share price went from approximately $1.20 per share to $0.10 per share significantly impacting the ability of Cobalis to launch PreHistin to world-wide markets as a nutraceutical allergy relief alternative to antihistamines or to secure funding for another Phase III FDA clinical trial. The resulting drop in Cobalis share price amounted to loss of approximately $60,000,000 in shareholder equity.

On August 1, 2007, less than seven months after execution of the PIPE transaction, YAGI involuntarily filed to convert Cobalis to Chapter 7 liquidation. It has been alleged that this was done ahead of the allowable cure periods for the alleged default as an attempt to prevent Cobalis from honoring its obligations pursuant to the PIPE transaction.

Following are a summary of the claims by Cobalis as filed in the lawsuit:

1. Two counts of Breach of Contract and allegations of equitable fraud.

2. Breach of contract and accumulating greater than 4.99% of Cobalis shares at one time.

3. Securities Fraud for violation of SEC Rule 10-b-5 relating to short selling without proper representation.

4. Equitable Fraud and Breach of Fiduciary Obligations by YAGI in collecting $415,000 in fees paid by Cobalis for execution of this PIPE transaction.

Cobalis is seeking for relief of costs and damages on all counts and for such further relief as the court deems just and proper. Tentative status conference hearing is scheduled for February 4, 2010.

Cobalis continues to operate and sell PreHistin under a Chapter 11 reorganization and has submitted a reorganization plan to the bankruptcy court that also has jurisdiction over this lawsuit, so they may be successfully discharged from bankruptcy.

The Cobalis Plan intends to pay back all creditors at 100% of allowable claims and also retains 100% of Cobalis shareholder equity. Cobalis believes YAGI may have already recouped all or more of their investment from their sale of 15,000,000 Cobalis shares. If Cobalis pays back YAGI in full, YAGI will be required to return over eight million (8,000,000) pledged shares of Cobalis stock.

YAGI has also submitted a competing plan to the bankruptcy court. Their plan, as filed with the court, intends to wipe-out the common stock of Cobalis and its shareholders, pay creditors 4 to 15 cents on the dollar, and allow 90 % of revenues from the world wide distribution of PreHistin to be accrued to a Canadian business entity alleged to have been recently purchased by YAGI and managed by a current YAGI principal.

The next CH 11 plan hearing date is December 16, 2009. Subsequently, creditors will be properly notified during January 2010 and have an opportunity to vote on the Cobalis Plan or the YAGI competing plan, if either or both, are approved by the court for plan confirmation vote by creditors.

Cobalis continues to execute their international sales, marketing, distribution and licensing strategies and their previously announced direct response television (DRTV) campaign for PreHistin. Current DRTV campaign launch is scheduled for December 26, 2009. Cobalis Corp is also initiating plans to return to fully reporting status in early 2010.

Visit http://otcpicknews.com/emailmarketer/link.phpM940&N0&L94&F=T to see the Cobalis lawsuit in its entirety.

ABOUT PREHISTIN PreHistin, the worlds first pre-histamine, has shown in previous studies to modulate the bodys level of protein IgE, reducing the overproduction of histamines, the primary cause of airborne allergy symptoms. Prior studies have shown that the active ingredient in PreHistin has essentially no risks or adverse effects to the general population including sedation and drowsiness found in most of the allergy products now available.

SOHM INCORPORATED (OTC: SHMN) "Up 41.30% on Monday" Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N0&L95&F=T SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India.

Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia.

SHMN News:

February 8 - SOHM India Enters High Growth Multi-Vitamin and Antioxidant Product Segment With Distribution in India and Emerging Target Markets Product Line Diversification and Distribution Into High Growth Niche Market a Priority for SOHM SOHM, Inc. (OTC: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, announced today that the Company has entered the multi-vitamin and antioxidant product segment in India and emerging target markets. The India market alone is estimated to be around $300 Million USD with a growth rate of 12 - 15 percent. The trend towards preventive healthcare in India makes diversifying into the production of nutraceuticals such as multi-vitamins and antioxidants a priority high growth market segment for SOHM.

Growth vectors for SOHM product lines in India and emerging target markets include the aging population, changing lifestyle, increasing medical costs, higher spending power, awareness of preventive medicine, and increasing malnutrition led diseases. SOHM has a competitive edge through the Company`s branding, pricing, promotional activities and distribution partners.

"As people in emerging markets such as India become more health-conscious they start to realize the need for dietary supplements to help them cope with the fast-changing pace of life," stated Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc. "Western work ethic and eating habits have put people at the risk of diabetes, cholesterol, heart ailments, arthritis and other ailments. The wide range of SOHM nutraceutical products including multi-vitamins and antioxidants help to reduce the risk of chronic disease and many people in India and emerging markets are realizing the benefits of prevention for the treatment of disease." CASCADIA INVESTMENTS INCORPORATED (OTC: CDIV) "Up 33.33% on Monday" Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N0&L96&F=T Cascadia Investments, Inc. is a publicly-traded, real estate development company operating in the Pacific Northwest. The company`s principal objective is to create equity and long-term earnings growth through the acquisition and development or renovation of undervalued and foreclosed real estate.

CDIV News:

January 20 - Cascadia Investments Signs Exclusive Licensing Agreement Cascadia Investments, Inc. (OTC: CDIV) announced that it has entered into an exclusive licensing agreement with Impulse Communications, Inc. to manage and develop a Facebook application featuring their brand AdoptMe.com.

AdoptMe.com is a virtual pet site where users adopt and interact with virtual pets. Cascadia plans to overhaul the current Facebook application as well as aggressively market it. The application will be monetized with incentive ads that reward users with game credits. The credits can then be used to purchase food, clothing, in-game items, and much more. In addition, users can also pay for these upgrades. Revenues from the application will be split equally between Cascadia and Impulse.

According to President and C.E.O. Nazir Maherali, this joint venture in conjunction with Cascadia`s recent acquisition of CustomFlashGames.com will allow us to create a series of AdoptMe themed games for the AdoptMe app as well as a series of related Flash-based Facebook applications, each launched independently of the other.

Impulse operates over 300 websites and 9,000 domain names that generate income from advertising, ecommerce, and domain name sales.

IRVINE SENSORS CORPORATION (NASDAQ: IRSN) "Up 29.63% on Monday" Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N0&L9&F=T Irvine Sensors Corporation, headquartered in Costa Mesa, California, is a vision systems company engaged in the development and sale of miniaturized infrared and electro-optical cameras, image processors and stacked chip assemblies and sale of higher level systems incorporating such products and research and development related to high density electronics, miniaturized sensors, optical interconnection technology, high speed network security, image processing and low-power analog and mixed-signal integrated circuits for diverse systems applications.

IRSN News:

February 8 - Irvine Sensors Receives Additional Order for `Clip-On` Thermal Imagers Will act as subcontractor in support of $37.8 million contract Irvine Sensors Corporation (Nasdaq: IRSN) announced that one of its existing purchase orders with Optics 1, Inc., of Manchester, New Hampshire, an optical systems designer and manufacturer, has been modified to include initial units of Clip-On Thermal Imager ("COTI") systems to be built under a $37.8 million contract recently awarded to Optics 1 by the Naval Surface Warfare Center of Crane, Indiana. The COTIs to be delivered under the new contract are intended for use by special operations forces. Irvine Sensors will be acting as a subcontractor supplying thermal imagers to Optics 1.

John Carson, Irvine Sensors CEO, said, "Once the required delivery schedules of the government customer are fully known, we expect that the amount of our subcontract will ultimately exceed $18 million in support of this job." Irvine Sensors and Optics 1 have been jointly developing the COTI over the last several years under government sponsorship, based on technology originally conceived by Irvine Sensors. The COTI has been designed to clip onto existing military night vision goggles and provide users with thermal images to complement the amplified low-light images that such goggles can currently provide. Such dual capability has been long sought by the military and is intended to both enhance imagery obtainable from the existing night vision goggles as well as providing images in circumstances where physical barriers, atmospheric conditions or lack of light limit the effectiveness of the existing goggles. There are presently about one million night vision goggles in U.S. military inventories that could potentially be retrofitted with the COTI system.

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stockbroker before investing.

Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward-looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company`s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward-looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company`s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company`s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://otcpicknews.com/emailmarketer/link.phpM940&N0&L=7&F=T and FINRA at http://otcpicknews.com/emailmarketer/link.phpM940&N0&L=8&F=T.

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.

ABOUT OTCPICKS.COM

OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover's Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks.com has not been compensated by any of the companies covered in this release. For a complete list of disclosures go to http://www.otcpicks.com/disclosure_details.php . The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor`s entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled.

The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company`s ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.

Third Party Web Sites and Information:

OTCPicks.com and newsletter may provide hyperlinks to third party websites or access to third party content. OTCPicks.com does not control, endorse, or guarantee content found in such sites. You agree that OTCPicks.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that OTCPicks.com shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

Disclaimer: http://www.otcpicks.com/disclaimer.htm

Disclosure Details: http://www.otcpicks.com/disclosure-details.htm

CONTACT: Brian Dean, Publisher, OTCPicks.com
Tel: +1 972 546 3740
EMail : publisher@otcpicks.com

See OTC Picks's website for full disclaimer. OTC Picks may have received compensation for stock picks.